{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:18:44Z","timestamp":1784801924832,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Prophylactic antibacterial drugs are used for patients with liver cirrhosis and upper gastrointestinal bleeding, and independent studies have concluded that they can decrease the rate of infection, mortality, and rebleeding in these diseases. However, no comprehensive assessment of this effect has been reported in recent years and available data pertaining to the prognostic implications of diverse categories of antibiotic prophylaxis in individuals afflicted with cirrhosis are notably limited. The objective of this article is to assess the clinical effectiveness of prophylactic antibacterial drugs for patients with liver cirrhosis and upper gastrointestinal bleeding.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Relevant randomized controlled studies and cohort studies which examined the value of prophylactic antibacterial drugs for patients with liver cirrhosis and upper gastrointestinal bleeding were retrieved via Cochrane Library, EMBASE, MedLine, and Web of Science. The search period was from database inception until 30 April 2023. Summing up the relevant data, the dichotomous variable was statistically analysed using the relative risk (RR) value and its 95% confidence interval (CI) and the continuous variable using the mean difference (MD) value and its 95% CI. All analyses were performed using Revman 5.4 software. The study has been registered on the PROSPERO website under registration number CRD42022343352.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Twenty-six studies (18 RCTs and 8 cohort studies, including 13,670 participants) were included to evaluate the effect of antibacterial prophylaxis <jats:italic>versus<\/jats:italic> no antibacterial prophylaxis or placebo. Prophylactic antibiotics reduced mortality rates (RR 0.66, 95% CI 0.51\u20130.83), infection rates (RR 0.41, 95% CI 0.35\u20130.49), rebleeding rates (RR 0.42, 95% CI 0.31\u20130.56), and length of hospital stay (MD \u22125.29, 95% CI \u22127.53, \u22123.04). Subgroup analysis revealed that the prophylactic administration of quinolone antimicrobials demonstrated the most favorable efficacy, followed by cephalosporins. Both interventions were effective in averting infections frequently observed in patients with liver cirrhosis and upper gastrointestinal bleeding.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Based on our investigation, the prophylactic antibacterial drugs confers noteworthy advantages in patients afflicted by liver cirrhosis with upper gastrointestinal bleeding. It has been associated with reductions in mortality, infection incidence, rebleeding occurrences, and the duration of hospitalization. Among prophylactic antibacterial options, quinolones emerged as the foremost choice, with cephalosporins ranking closely thereafter.<\/jats:p><jats:p>Systematic Review Registration: <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022343352<\/jats:ext-link>, identifier CRD42022343352.<\/jats:p>","DOI":"10.3389\/fphar.2024.1324848","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T05:09:06Z","timestamp":1710392946000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness of prophylactic antibacterial drugs for patients with liver cirrhosis and upper gastrointestinal bleeding: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Zhuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Shuo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Mei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J. Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s10620-019-05519-4","article-title":"Evidence of significant ceftriaxone and quinolone resistance in cirrhotics with spontaneous bacterial peritonitis","volume":"64","author":"Ardolino","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American association for the study of liver diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/0270-9139(94)90131-7","article-title":"Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage","volume":"20","author":"Blaise","year":"1994","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0229101","DOI":"10.1371\/journal.pone.0229101","article-title":"Limited effects of antibiotic prophylaxis in patients with Child-Pugh class A\/B cirrhosis and upper gastrointestinal bleeding","volume":"15","author":"Chang","year":"2020","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","article-title":"Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review","volume":"34","author":"Chavez-Tapia","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B7","first-page":"885","article-title":"Expert Consensus on Diagnosis and Treatment of esophageal and fundus varices rupture and Hemorrhage in Cirrhotic portal hypertension","volume":"57","author":"Chinese Society Of Spleen And Portalhypertension Surgery","year":"2019","journal-title":"Chin. J. Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"De Franchis","year":"2022","journal-title":"J. Hepatol."},{"key":"B9","first-page":"133","article-title":"To observe the clinical effect of antibacterial drugs on preventing nosocomial infection in patients with upper gastrointestinal bleeding due to liver cirrhosis","volume":"19","author":"Fu","year":"2015","journal-title":"J. Clin. Med. Pract."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1056\/NEJMc1612334","article-title":"Treatment of patients with cirrhosis","volume":"375","author":"Ge","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"key":"B12","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/hep.20126","article-title":"Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial","volume":"39","author":"Hou","year":"2004","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1572-0241.1998.00288.x","article-title":"The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding","volume":"93","author":"Hsieh","year":"1998","journal-title":"Am. J. Gastroenterology"},{"key":"B14","first-page":"2427","article-title":"Analysis of risk factors of nosocomial infections in cirrhotic patients with upper gastrointestinal hemorrhage and the preventive effect of antibacterials","volume":"28","author":"Jiang","year":"2018","journal-title":"Chin. J. Nosocomiology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3346\/jkms.2006.21.5.883","article-title":"Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study","volume":"21","author":"Jun","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/ajg.2009.750","article-title":"A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis","volume":"105","author":"Kim","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.3748\/wjg.v20.i7.1790","article-title":"Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding","volume":"20","author":"Lee","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.cgh.2016.05.040","article-title":"Use of antibiotics among patients with cirrhosis and upper gastrointestinal bleeding is associated with reduced mortality","volume":"14","author":"Moon","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B19","first-page":"46","article-title":"The value of antibiotics in preventing nosocomial infection in patients with upper gastrointestinal bleeding due to liver cirrhosis","volume":"22","author":"Na","year":"2017","journal-title":"Mod. Dig. Intervention"},{"key":"B20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/liv.13645","article-title":"Infections complicating cirrhosis","volume":"38","author":"Piano","year":"2018","journal-title":"Liver Int."},{"key":"B21","first-page":"48","article-title":"Analysis of the effect of prophylactic application of antibiotics on infection in cirrhotic patients with upper gastrointestinal bleeding","volume":"36","author":"Qin","year":"2020","journal-title":"Chin. COMMUNITY Dr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/hep.1840050320","article-title":"Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage","volume":"5","author":"Rimola","year":"1985","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/s0168-8278(05)80272-7","article-title":"Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis","volume":"18","author":"Rolando","year":"1993","journal-title":"J. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/s0016-5107(94)70109-1","article-title":"Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous vefotaxime: a randomized trial","volume":"40","author":"Selby","year":"1994","journal-title":"Gastrointest. Endosc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/0016-5085(92)91514-5","article-title":"Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage","volume":"103","author":"Soriano","year":"1992","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2014.11.019","article-title":"Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on child-pugh class, and effects of antibiotics","volume":"13","author":"Tandon","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e19981","DOI":"10.1097\/MD.0000000000019981","article-title":"Universal antibiotic prophylaxis may no longer be necessary for patients with acute variceal bleeding A retrospective observational study","volume":"99","author":"Ueno","year":"2020","journal-title":"Medicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/jgh.14873","article-title":"The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis","volume":"35","author":"Wu","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B30","first-page":"172","article-title":"Effect of antibiotic prophylaxis on nosocomial infection in cirrhotic patients with gastrointestinal hemorrhage","volume":"12","author":"Wu","year":"2002","journal-title":"Chin. J. Nosocomiology"},{"key":"B31","first-page":"68","article-title":"Effect of prophylactic application of antibiotics on nosocomial infection in patients with cirrhosis and upper gastrointestinal hemorrhage","volume":"23","author":"Wu","year":"2019","journal-title":"J. Clin. Med. Pract."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/s00464-011-1642-0","article-title":"The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions","volume":"25","author":"Xu","year":"2011","journal-title":"Surg. Endosc."},{"key":"B33","first-page":"8","article-title":"Effect of prophylactic antibiotics on infection in patients with liver cirrhosis and upper gastrointestinal hemorrhage","volume":"16","author":"Xu","year":"2021","journal-title":"China Prac. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s10620-022-07481-0","article-title":"Antibiotic prophylaxis for upper gastrointestinal bleed in liver cirrhosis; less may Be more","volume":"68","author":"Y","year":"2023","journal-title":"Dig. Dis. Sci."},{"key":"B35","first-page":"132","article-title":"The effect of prophylactic use of antibiotics on patients with liver cirrhosis complicated with upper gastrointestinal bleeding","volume":"20","author":"Yang","year":"2015","journal-title":"Chin. Hepatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00535-021-01788-x","article-title":"Evidence-based clinical practice guidelines for Liver Cirrhosis 2020","volume":"56","author":"Yoshiji","year":"2021","journal-title":"J. Gastroenterol."},{"key":"B37","first-page":"2064","article-title":"Effect of antibiotics prophylaxis on noscocomial infections in liver cirrhotic patients with acute upper gastrointestinal hemorrhage","volume":"23","author":"Yu","year":"2013","journal-title":"Chin. J. Nosocomiology"},{"key":"B38","first-page":"70","article-title":"Clinical impact analysis of prophylactic use of antibiotics in patients with liver cirrhosis upper gastrointestinal bleeding infection","volume":"39","author":"Zhang","year":"2018","journal-title":"J. Med. Forum"},{"key":"B39","first-page":"2317","article-title":"Clinical effect of prophylactic use of antibiotics on nosocomial infection in cirrhotic patients with gastrointestinal hemorrhage","volume":"21","author":"Zhu","year":"2011","journal-title":"Chin. J. Nosocomiology"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1324848\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T05:09:18Z","timestamp":1710392958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1324848\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":39,"alternative-id":["10.3389\/fphar.2024.1324848"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1324848","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]},"article-number":"1324848"}}